{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:27:36Z","timestamp":1788838056945,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005826","name":"Agricultural Marketing Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.alit.2019.10.011","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T09:27:48Z","timestamp":1575451668000},"page":"215-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency"],"prefix":"10.1016","volume":"69","author":[{"given":"Angelica","family":"Tiotiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Salvator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Jaussaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Jean","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Catherinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Devillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2019.10.011_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11882-017-0678-1","article-title":"Phenotype-driven therapeutics in severe asthma","volume":"17","author":"Opina","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.alit.2019.10.011_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02448-2016","article-title":"Addressing unmet needs in understanding asthma mechanisms: from the European asthma research and innovation partnership (EARIP) work package (WP)2 collaborators","volume":"49","author":"Edwards","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2019.10.011_bib4","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/S0140-6736(03)13582-9","article-title":"Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children","volume":"361","author":"Chauhan","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2019.10.011_bib5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.scitotenv.2014.10.003","article-title":"Greater temperature variation within a day associated with increased emergency hospital admissions for asthma","volume":"505","author":"Qiu","year":"2015","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.alit.2019.10.011_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0037-1607391","article-title":"Diagnosis and management of severe asthma","volume":"39","author":"Chung","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.alit.2019.10.011_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2019.10.011_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/resp.13026","article-title":"Co-morbidities in severe asthma: clinical impact and management","volume":"22","author":"Porsbjerg","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.alit.2019.10.011_bib9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.rmed.2017.10.016","article-title":"Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease","volume":"132","author":"Berger","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2019.10.011_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.aller.2013.09.014","article-title":"Bronchial hyperreactivity in children with antibody deficiencies","volume":"43","author":"\u00d6zcan","year":"2015","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.alit.2019.10.011_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1399-3038.2010.01105.x","article-title":"Serum immunoglobulin levels as a predictive factor for a better outcome of non-atopic childhood asthma","volume":"22","author":"Baris","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib13","first-page":"472","article-title":"Hypogammaglobulinemia in asthmatic patients","volume":"68","author":"Hamilos","year":"1992","journal-title":"Ann Allergy"},{"key":"10.1016\/j.alit.2019.10.011_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.mayocp.2013.05.021","article-title":"Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study","volume":"88","author":"Urm","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.alit.2019.10.011_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4168\/aair.2017.9.6.526","article-title":"Effects of immunoglobulin replacement on asthma exacerbation in adult asthmatics with IgG subclass deficiency","volume":"9","author":"Kim","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.alit.2019.10.011_bib16","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s10875-016-0335-9","article-title":"Asthma and hypogammaglobulinemia: an asthma phenotype with low type 2 inflammation","volume":"36","author":"Dupin","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib17","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3346\/jkms.2016.31.10.1560","article-title":"Immunoglobulin G subclass deficiencies in adult patients with chronic airway diseases","volume":"31","author":"Kim","year":"2016","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.alit.2019.10.011_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3904\/kjim.2018.413","article-title":"Association between primary immunodeficiency and asthma exacerbation in adult asthmatics","volume":"35","author":"Lee","year":"2020","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.alit.2019.10.011_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2045-7022-3-3","article-title":"The skin prick test \u2013 European standards","volume":"3","author":"Heinzerling","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.alit.2019.10.011_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/CVI.00735-14","article-title":"Use and clinical interpretation of pneumococcal antibody measurements in the evaluation of humoral immune function","volume":"22","author":"Daly","year":"2015","journal-title":"Clin Vaccin Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2019.10.011_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","article-title":"Identifying \u2018well-controlled\u2019 and \u2018not well-controlled\u2019 asthma using the Asthma Control Questionnaire","volume":"100","author":"Juniper","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2019.10.011_bib23","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/thx.2006.061648","article-title":"Standardisation of lung function testing: helpful guidance from the ATS\/ERS Task Force","volume":"61","author":"Laszlo","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2019.10.011_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cea.12179","article-title":"Frequent exacerbators \u2013 a distinct phenotype of severe asthma","volume":"44","author":"Kupczyk","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2019.10.011_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1398-9995.2009.02211.x","article-title":"Allergic asthma in patients with common variable immunodeficiency","volume":"65","author":"Agondi","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2019.10.011_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/sji.12551","article-title":"Identification and characterization of a nationwide Danish adult common variable immunodeficiency cohort","volume":"85","author":"Westh","year":"2017","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib27","first-page":"106","article-title":"IgG3 deficiency: common in obstructive lung disease. Hereditary in families with\u00a0immunodeficiency and autoimmune disease","volume":"20","author":"Oxelius","year":"1986","journal-title":"Monogr Allergy"},{"key":"10.1016\/j.alit.2019.10.011_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000199723","article-title":"Efficacy of intravenous gamma globulin for immunoglobulin G subclass and\/or antibody deficiency in adults","volume":"149","author":"Abdou","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/00365540600951192","article-title":"Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up","volume":"39","author":"Olinder-Nielsen","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.alit.2019.10.011_bib31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijantimicag.2010.11.027","article-title":"Immunoglobulin treatment in primary antibody deficiency","volume":"37","author":"Maarschalk-Ellerbroek","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.alit.2019.10.011_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ebiom.2017.03.025","article-title":"Long-term clinical outcome of antibody replacement therapy in humoral immunodeficient adults with respiratory tract infections","volume":"18","author":"van Kessel","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.alit.2019.10.011_bib33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s10875-018-0566-z","article-title":"Home-based treatment with immunoglobulins: an evaluation from the perspective of patients and healthcare professionals","volume":"38","author":"Zuizewind","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0091-6749(93)90179-J","article-title":"Therapy for patients with recurrent infections and low serum IgG3 levels","volume":"92","author":"Barlan","year":"1993","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fimmu.2019.00033","article-title":"The expanding field of secondary antibody deficiency: causes, diagnosis, and management","volume":"10","author":"Patel","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1445-5994.2003.t01-1-00419.x","article-title":"Role of intravenous immunoglobulin in severe steroid-dependent asthma","volume":"33","author":"Haque","year":"2003","journal-title":"Intern Med J"},{"key":"10.1016\/j.alit.2019.10.011_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/clim.1999.4714","article-title":"A\u00a0multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma","volume":"91","author":"Kishiyama","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib38","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0091-6749(99)70424-0","article-title":"Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial","volume":"103","author":"Salmun","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2222.1998.00214.x","article-title":"Prospective, double-blind, placebo-controlled, multicentre study on the effect of high-dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthma","volume":"28","author":"Niggemann","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2019.10.011_bib40","first-page":"53","article-title":"The response to intravenous immunoglobulin replacement therapy in patients with asthma with specific antibody deficiency","volume":"27","author":"Schwartz","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.alit.2019.10.011_bib41","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10875-016-0327-9","article-title":"Efficacy, safety, and pharmacokinetics of a novel human immune globulin subcutaneous, 20 % in patients with primary immunodeficiency diseases in north America","volume":"36","author":"Suez","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10875-012-9656-5","article-title":"Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency","volume":"32","author":"Wasserman","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2019.10.011_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/cei.13012","article-title":"Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group","volume":"190","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.alit.2019.10.011_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02523-2017","article-title":"Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study","volume":"51","author":"Humbert","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2019.10.011_bib46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1378\/chest.12-1372","article-title":"Pharmacoepidemiology of Asthma and Xolair (PAX) Study Group. Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: results from a large cohort of patients with severe uncontrolled asthma","volume":"143","author":"Grimaldi-Bensouda","year":"2013","journal-title":"Chest"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019301753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019301753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:10:36Z","timestamp":1761156636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893019301753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1323893019301753"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2019.10.011","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2019.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}